Ethyl Linoleate

Ethyl Linoleate

SCHEMBL2019418

CCCCCC=CCC=CCCCCCCCC(=O)OCC

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.82
CYP3A4 P08684 2/20 0.82
ALOX15 P16050 2/20 0.82
TSHR P16473 2/20 0.82
HSD17B10 Q99714 2/20 0.82
TDP1 Q9NUW8 2/20 0.82
NR1I2 O75469 1/20 0.71
PGR P06401 1/20 0.71
ADORA3 P0DMS8 1/20 0.71
PTGS2 P35354 1/20 0.71
PDE4D Q08499 1/20 0.71
MGLL Q99685 1/20 0.68
MAPT P10636 1/20 0.66
THRB P10828 1/20 0.66
CNR1 P21554 1/20 0.66
F7 P08709 4/20 0.65
F3 P13726 4/20 0.65
KDM4E B2RXH2 3/20 0.65
PPARG P37231 3/20 0.65
PPARD Q03181 3/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3046418 1.00 ALDH1A1 (0.82) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
Ethyl Linoleate SCHEMBL81540 1.00 ALDH1A1 (0.82) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL3046420 1.00 ALDH1A1 (0.82) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
Ethyl Linoleate SCHEMBL15469171 1.00 ALDH1A1 (0.82) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL8982666 1.00 ALDH1A1 (0.82) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
Ethyl Linoleate SCHEMBL2019416 1.00 ALDH1A1 (0.82) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL6808633 1.00 ALDH1A1 (0.82) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL6808635 1.00 ALDH1A1 (0.82) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL6808235 1.00 ALDH1A1 (0.82) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL31264381 1.00 ALDH1A1 (0.82) ALDH1A1CYP3A4ALOX15TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118516182-A Method for simultaneously and targeted extraction of various characteristic aroma substances in white spirit byproducts and application thereof 贵州茅台酒股份有限公司 2024-08-20 CN claimed
CN-116769619-B Candida B2, capsicum product and method 湖南坛坛香食品科技有限公司 2024-02-27 CN claimed
CN-116769619-A Candida B2, capsicum product and method 湖南坛坛香食品科技有限公司 2023-09-19 CN claimed
US-10668122-B2 Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic disease, the preparation method and the use thereof METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) 2020-06-02 US claimed
US-20170252393-A1 EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASE, THE PREPARATION METHOD AND THE USE THEREOF METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) 2017-09-07 US claimed
CN-102793804-A Viola yedoensis makino petroleum ether extract and medicinal application thereof UNIV FUDAN 2012-11-28 CN claimed
EP-2519244-A1 EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASES, THE PREPARATION METHOD AND THE USE THEREOF Kaohsiung Medical University (TW) 2012-11-07 EP claimed
WO-2011082148-A1 EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASES, THE PREPARATION METHOD AND THE USE THEREOF KAOHSIUNG MEDICAL UNIVERSITY (TW) 2011-07-07 WO claimed
US-20110159127-A1 EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASES, THE PREPARATION METHOD AND THE USE THEREOF METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) 2011-06-30 US claimed
EP-4686757-A1 INHIBITORS OF EXPRESSION AND/OR FUNCTION e-therapeutics PLC (GB) 2026-02-04 EP disclosed
EP-2925139-B1 FERMENTED SOIL ADDITIVE LIQUID FERTILISER SYSTEMS PTY LTD (AU) 2025-04-30 EP disclosed
EP-4452934-A1 IONIZABLE DISULFIDE LIPIDS AND LIPID NANOPARTICLES DERIVED THEREFROM Providence Therapeutics Holdings Inc. (CA) 2024-10-30 EP disclosed
CN-118516182-A Method for simultaneously and targeted extraction of various characteristic aroma substances in white spirit byproducts and application thereof 贵州茅台酒股份有限公司 2024-08-20 CN disclosed
EP-4402121-A1 ACYCLIC LIPIDS AND METHODS OF USE THEREOF Renagade Therapeutics Management Inc. (US) 2024-07-24 EP disclosed
EP-0014745-A1 Curing agent for polyepoxides, curable epoxy resin compositions, hardened products therefrom and process for curing a polyepoxide DIAMOND SHAMROCK CORPORATION (US) 1980-09-03 EP disclosed
US-4177173-A INFUSIBLE FILMS, CASTINGS OR ADHESIVES DIAMOND SHAMROCK CORPORATION (US) 1979-12-04 US disclosed
US-4118535-A SOLVENTLESS-DRY POWDER COATINGS, FILAMENTS, FIBERS, FILMS, MOLDING COMPOUNDS GENERAL ELECTRIC COMPANY (US) 1978-10-03 US disclosed
US-4065316-A EPOXY RESIN, METHYLATED AMINO RESIN AND PIGMENT WESTERN ELECTRIC COMPANY, INCORPORATED (US) 1977-12-27 US disclosed
US-4034014-A FROM MALEIC MONOMERS AND ALKYLSTYRENES ALLIED CHEMICAL CORPORATION (US) 1977-07-05 US disclosed
US-3948855-A Process for reacting a phenol with a vicinal epoxy compound in the presence of phosphorus or carbon containing acid, ester or acid ester THE DOW CHEMICAL COMPANY (US) 1976-04-06 US disclosed